Compare Brevis (BREV) vs Mitosis (MITO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brevis vs Mitosis — how do they compare? Brevis trades at Rp1,218 (market cap Rp304,11M, Rp159,56M 24h volume), while Mitosis trades at Rp451.43 (market cap Rp81,85M, Rp73,88M 24h volume). The key difference: Brevis is far larger — about 3.7× Mitosis's market cap, and Brevis's circulating supply is 250M / 1B BREV (25%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Brevis for 8 Days and Mitosis for 20 Days on average.
| BREV | MITO | |
|---|---|---|
Market Cap | Rp304,11M | Rp81,85M |
Volume (24h) | Rp159,56M | Rp73,88M |
Circulating Supply | 250M / 1B BREV (25%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 8 Days | 20 Days |
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →About Mitosis
Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →
